ARCHIVES

“Our Job Is to Be The One Agency That Speaks To Cancer”

This article is from The Cancer Letter archive.

Vol. 20 No. 41 | October 28, 1994

Download PDF Visit The Full Archive

Related Articles

Revlimid Extends Time To Progression Compared To Placebo In Phase III Trial

December 25, 2009

ODAC Recommends Taxol For Metastatic Breast Cancer

January 7, 1994

Recombinant TSH Avoids Need To Stop Replacement Therapy

January 27, 2006

Advisors Approve CCOP, EDRN, Pediatric Brain Tumor Network Renewal

March 28, 2003

NCI Cooperative Group Clinical Trials Approved

February 26, 2010

Oblimersen Combination Improves CLL Survival

December 28, 2007